Success Metrics

Clinical Success Rate
50.0%

Based on 3 completed trials

Completion Rate
50%(3/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
3(43%)

Phase Distribution

Ph phase_3
2
29%
Ph not_applicable
5
71%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 3Large-scale testing
2(28.6%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(3)
Terminated(3)
Other(1)

Detailed Status

Completed3
Terminated3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (28.6%)
N/A5 (71.4%)

Trials by Status

unknown114%
completed343%
terminated343%

Recent Activity

0 active trials
Showing 5 of 7
completednot_applicable

Partnership to Improve Nutrition and Adiposity in Prenatal Clinical Care: a Pilot and Feasibility Study

NCT02520167
completednot_applicable

Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia and Hyperferritinemia

NCT02526121
completednot_applicable

Effects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload Patients

NCT01572818
unknownnot_applicable

Dietary Intervention to Stop COronary Atherosclerosis in Computed Tomography

NCT02571803
terminatedphase_3

GALLANT 2 Tesaglitazar vs. Placebo

NCT00252772
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT02520167Not Applicable

Partnership to Improve Nutrition and Adiposity in Prenatal Clinical Care: a Pilot and Feasibility Study

Completed
NCT02526121Not Applicable

Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia and Hyperferritinemia

Completed
NCT01572818Not Applicable

Effects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload Patients

Completed
NCT02571803Not Applicable

Dietary Intervention to Stop COronary Atherosclerosis in Computed Tomography

Unknown
NCT00252772Phase 3

GALLANT 2 Tesaglitazar vs. Placebo

Terminated
NCT00792480Not Applicable

Does Dietary and Lifestyle Counseling Prevent Excessive Weight Gain During Pregnancy? A Randomized Controlled Trial

Terminated
NCT00252837Phase 3

GALLANT 22 Tesaglitazar vs. Placebo

Terminated

All 7 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
7